Home › NDC Lookup › RxCUI directory › RxCUI 207198

1 ML octreotide 0.1 MG/ML Injection [Sandostatin] — RxCUI 207198

Name: 1 ML octreotide 0.1 MG/ML Injection [Sandostatin] (RxCUI 207198)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 207198 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI207198

Official name1 ML octreotide 0.1 MG/ML Injection [Sandostatin]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as1 ML Sandostatin 0.1 MG/ML Injection; SandoSTATIN 100 MCG in 1 ML Injection; Sandostatin 100 MCG per 1 ML Injection

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)22 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Octreotide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Octreotide works like a more powerful version of a natural hormone in your body called somatostatin. Depending on what it's prescribed for, it either lowers your growth hormone lev...
What exactly does octreotide do — and why do I need it?
Yes, timing around food matters a lot with Mycapssa. You need to take it on a completely empty stomach — at least one hour before you eat anything, or at least two hours after your...
How do I take Mycapssa correctly — does it matter if I eat first?

📖 Read our full Octreotide guide →

🕸️ Concept Web — How 1 ML octreotide 0.1 MG/ML Injection [Sandostatin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1 ML octreotide 0.1 MG/ML Injection [Sandostatin] RxCUI 207198 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Octreotide 7617 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Sandostatin 196457 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Octreotide Injection 1654342 SCDF
- Octreotide Injectable Product 1160449 SCDG
- Octreotide Injection [Sandostatin] 1654344 SBDF
- Sandostatin Injectable Product 1185966 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 1 ML octreotide 0.1 MG/ML Injection 312069 SCD
- Octreotide 0.1 MG/ML 328442 SCDC
- Octreotide 0.1 MG/ML [Sandostatin] 567989 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

1 ML octreotide 0.1 MG/ML Injection SCD · 312069
Octreotide 0.1 MG/ML SCDC · 328442
Octreotide Injection SCDF · 1654342
Octreotide Injectable Product SCDG · 1160449

Brand-Name Concepts

Octreotide 0.1 MG/ML [Sandostatin] SBDC · 567989
Octreotide Injection [Sandostatin] SBDF · 1654344
Sandostatin Injectable Product SBDG · 1185966
Sandostatin BN · 196457

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 207198 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00078-0180-01	10 AMPULE in 1 PACKAGE (0078-0180-01) / 1 mL in 1 AMPULE (0...	Sandostatin	Novartis Pharmaceuticals Corporation	1988-10-21
00078-0181-01	10 AMPULE in 1 PACKAGE (0078-0181-01) / 1 mL in 1 AMPULE (0...	Sandostatin	Novartis Pharmaceuticals Corporation	1988-10-21
00078-0182-01	10 AMPULE in 1 PACKAGE (0078-0182-01) / 1 mL in 1 AMPULE (0...	Sandostatin	Novartis Pharmaceuticals Corporation	1988-10-21

Observed labelers: Novartis Pharmaceuticals Corporation (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2354	Octreotide inj, non-depot	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.